Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05188248 · ClinicalTrials.gov registry record · NA
A Pilot Study of the Immediate Effects of DLPFC tDCS on Attention Bias in Depression
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT05188248 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 21 participants.
The verdict
NCT05188248, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Depression and other psychiatric conditions are marked by exaggerated, preferential processing (or attention bias) of negative information relative to neutral or positive information. This depression-related attention bias can be measured using the Dot Probe task and Visual Search, that allow assessment of the degree to which one shows bias toward negative information in the presence of neutral or positive information. A clinically effective treatment for depression is noninvasive brain stimulation with transcranial direct current stimulation (tDCS), targeting the dorsolateral prefrontal cortex (DLPFC), delivered in repeated sessions across a period of time. The study will test the effect of a single session of DLPFC tDCS on attention bias in patients with mild to moderate depression.
Interventions
- DEVICE Transcranial direct current stimulation (tDCS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2021-12-15 |
| Est. Completion | 2022-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05188248
The ClinicalTrials.gov registry entry for NCT05188248 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial direct current stimulation (tDCS) is the first listed.
NCT05188248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05188248 about?
NCT05188248 is a clinical study titled "A Pilot Study of the Immediate Effects of DLPFC tDCS on Attention Bias in Depression". Depression and other psychiatric conditions are marked by exaggerated, preferential processing (or attention bias) of negative information relative to neutral or positive information. This depression-related attention bias can be measured using the Dot Probe task and Visual Search, that allow assess...
What is the current status of trial NCT05188248?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2021-12-15. Estimated completion is 2022-12-14.
What interventions are being tested in trial NCT05188248?
The interventions under investigation include: Transcranial direct current stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT05188248?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.